Mitochondrial function and Aβ in Alzheimer's disease postmortem brain

Neurobiol Dis. 2022 Sep:171:105781. doi: 10.1016/j.nbd.2022.105781. Epub 2022 Jun 3.

Abstract

Introduction: Mitochondrial dysfunction is observed in Alzheimer's disease (AD). However, the relationship between functional mitochondrial deficits and AD pathologies is not well established in human subjects.

Methods: Post-mortem human brain tissue from 11 non-demented (ND) and 12 AD subjects was used to examine mitochondrial electron transport chain (ETC) function. Data were analyzed by neuropathology diagnosis and Apolipoprotein E (APOE) genotype. Relationships between AD pathology and mitochondrial function were determined.

Results: AD subjects had reductions in brain cytochrome oxidase (COX) function and complex II Vmax. APOE ε4 carriers had COX, complex II and III deficits. AD subjects had reduced expression of Complex I-III ETC proteins, no changes were observed in APOE ε4 carriers. No correlation between p-Tau Thr 181 and mitochondrial outcomes was observed, although brains from non-demented subjects demonstrated positive correlations between Aβ concentration and COX Vmax.

Discussion: These data support a dysregulated relationship between brain mitochondrial function and Aβ pathology in AD.

Keywords: Alzheimer's disease; Aβ; Brain; Cytochrome oxidase; Mitochondria.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Apolipoprotein E4 / metabolism
  • Autopsy
  • Brain / metabolism
  • Electron Transport Complex IV / metabolism
  • Humans
  • Mitochondria / metabolism

Substances

  • Amyloid beta-Peptides
  • Apolipoprotein E4
  • Electron Transport Complex IV